Navigation Links
Mouse Anti-Human QDPR Monoclonal Antibody, Unconjugated, Clone 2D4-1D3 from Novus Biologicals

ProductsMouse Anti-Human QDPR Monoclonal Antibody, Unconjugated, Clone 2D4-1D3 from Novus Biologicals
Company Novus Biologicals
Item Mouse Anti-Human QDPR Monoclonal Antibody, Unconjugated, Clone 2D4-1D3
Price $275.00
Description Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase
Info Novus BiologicalsNovus Biologicals
8100 Southpark Way
Unit A-8
Littleton, CO 80120
Customer Service: (888) 506-6887
Tech Support: (303) 730-1950
Fax Number: (303) 730-1966
Web Site: http://www.novusbio.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Mouse Anti-Amodiaquine Monoclonal Antibody, Unconjugated, Clone 6D10 from AntibodyShop A/S
2. Mouse Anti-Protein S Monoclonal Antibody, Unconjugated, Clone HYB 232-02 from Abcam
3. Mouse Anti-Mouse Glutathione S-transferase M1 (GSTM1) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
4. Mouse Anti-Human S-100 alpha/beta chain Monoclonal Antibody, Unconjugated, Clone 8B10 from Santa Cruz Biotechnology, Inc.
5. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Testis from OriGene Technologies
6. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Brain (adult) from OriGene Technologies
7. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Embryo (12.5 - day) from OriGene Technologies
8. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Embryo (19 - day) from OriGene Technologies
9. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Thymus from OriGene Technologies
10. Mouse Anti-Human Complement factor B Monoclonal Antibody, Unconjugated, Clone 9B6 from AntibodyShop A/S
11. Mouse Anti-Human Choriongonadotropin (hCG) Monoclonal Antibody, Unconjugated, Clone 5F10 from AntibodyShop A/S
...or (PR) Competitor Assay Kits are ideal for studyi...g compounds using fluorescence polarization (FP). ...one transferase to the ligand binding domain of hu...rietary, fluorescently tagged progesterone ligand,...
Organic Acid Analysis Standard, 6 vials from Bio-Rad
...r Imaging Systems group announces the availability...ms, featuring high resolution cooled CCD camera te...nce, radiographic and chromogenic imaging capabili...l zoom lens provides spatial resolution of up to 1...
...e and size analyzer offering a wide dynamic range....n mind. It is comprised of a chemically compatible...system is completely computer controlled. The modu...pplications such as dry or where smaller volumes a...
Biology Products:
(Date:11/9/2009)... inspired a 3.2m, three-year research project that...ecurity, energy and the environment. The Universit...inetiQ have just signed a collaborative contract t... physical sciences research. , Over the next th... of Exeter and QinetiQ will work together to devel...
(Date:11/9/2009)...eaders from around the world will gather in Boston...r Targets and Cancer Therapeutics International Co...ation on important cancer therapies in development...t effectively we need a greater understanding of t...l," said Lewis Cantley, Ph.D., director of the can...
(Date:11/8/2009)...S WITH INTELLECTUAL DISABILITIES: AN OPPORTUNITY F...y involving adults with intellectual disabilities ...lth knowledge after taking a semi-weekly class for...ly accepted term for mental retardation, have slig...and preventable chronic diseases compared to the g...
Breaking Biology News(10 mins):£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Nevada Drug Card and Las Vegas Chamber Offer Rx Assistance 52973 1Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 1Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 2Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 3Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 4New drug for children with high risk leukemia 52965 1New drug for children with high risk leukemia 52965 2
... of a sustainable biofuels industry in Tennessee h... of Energy has announced that Mascoma Corporation,...cipients of a $26 million grant for the developmen...s for demonstrating the production of cellulosic e... operations. The facility is to be constructed at ...
..., including malaria, dengue fever, and avian influ...l factors and, more recently, to climate change. R...e animals that carry and ultimately transmit these...occurs, these diseases may be introduced into area...standing the interactions that occur among climate...
...nse of Arctic sea ice is increasingly vulnerable t...dy, by scientists at the National Center for Atmos...ty (CSU), finds that unusually sunny weather contr... while similar weather conditions in past summers ...he study, which draws on observations from instrum...
Other Biology News:Mascoma and UT join in $26M DOE grant 2Mascoma and UT join in $26M DOE grant 3Scientists to explore global change-public health connection 2Arctic ice more vulnerable to sunny weather, new study shows 2Arctic ice more vulnerable to sunny weather, new study shows 3
(Date:11/5/2009)...ORDOVA, Calif., Nov. 5 T...plier of innovative products for processing and st... the first quarter of fiscal 2010. ,, For the q...ted revenues of $5.2 million, a 15 percent increas...er a year ago. The Company said the key contributo...
(Date:11/5/2009)...eb., Nov. 5 Transgenomic...financial results for the quarter ended September ...ented in the tables that follow. ,, Third Quar... $366,000 or $0.01 per share for the third quarter...$0.01 per share for the third quarter of 2008. ,...
(Date:11/5/2009)...E, Calif., Nov. 5 Cephei...ives will be speaking at the following investor co...a webcast. , , Credit Suisse Healt...rsday, 12 November, 2009 at 10 a.m. Mountain Time,..., London, England, Tuesday, 1 Dece...
(Date:11/5/2009)...O, CA, November 5, 2009 ...on using proprietary taste receptor-based technolo...food, beverage, and ingredient supply industries, ...ancial results for the third quarter ended Septemb...hird quarter of 2009, compared to $4.0 million for...
Breaking Biology Technology:ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14